期刊文献+

干性年龄相关性黄斑变性的药物治疗最新研究进展 被引量:4

Recent progress of drug treatment to age-related macular degeneration
下载PDF
导出
摘要 年龄相关性黄斑变性(age-related macular degeneration,AMD)是西方国家老年人低视力和致盲的主要病因,AMD已成为眼科学研究的热点。根据临床及病理表现,可将AMD分为干性和湿性两种类型,干性约占90%。因此,本文针对干性AMD的病理生理机制及新近的药物治疗方法进行了分析总结。为今后ADM的治疗提出依据。 Age-related macular degeneration (AMD) was a main cause leading to low vision and blindness of theWestern countries elderly population. AMD has become a hotspot in the ophthalmology research. According to the clinical and pathological finding, it was divided to the dry and wet two types, and the dry type was accounting for about 90 percent. So the aim of the article was to analyze and summarize the pathophysiological mechanisms and recent drug treatment methods to the dry AMD, so as to provide evidence for the future treatment of AMD.
作者 马臻 王雨生
出处 《国际眼科杂志》 CAS 2013年第2期289-291,共3页 International Eye Science
关键词 年龄相关性黄斑变性 作用机制 治疗方法 age - related macular degeneration pathophysiological mechanisms treatment methods
  • 相关文献

参考文献29

  • 1Hogg RE,Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy[J].Progress in Retinal and Eye Research,2006,(03):249-276.
  • 2Age-Related Eye Disease Study Research Group. A randomized,placebo-controlled,clinical trial of high-dose supplementation with vitamins C and E,beta carotene,and zinc for age-related macular degeneration and vision loss:AREDS report no8[J].Archives of Ophthalmology,2001,(10):1417-1436.
  • 3Age-Related Eye Disease Study Research Group. A randomized,placebo-controlled,clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss:AREDS report no9[J].Archives of Ophthalmology,2001,(10):1439-1452.
  • 4Zarbin MA. Current concepts in the pathogenesis of age-related macular degenera-tion[J].Archives of Ophthalmology,2004,(04):598-614.
  • 5Holz FG,Bellman C,Staudt S. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration[J].Investigative Ophthalmology & Visual Science,2001,(05):1051-1056.
  • 6Hageman GS,Luthert PJ,Victor Chong NH. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration[J].Progress in Retinal and Eye Research,2001,(06):705-732.
  • 7Donoso LA,Kim D,Frost A. The role of inflammation in the pathogenesis of age-related macular degeneration[J].Survey of Ophthalmology,2006,(02):137-152.
  • 8Grindle CFJ,Marshall J. Ageing changes in Bruch's membrane and their functional implications[J].Transactions of the Ophthalmological Societies of the United Kingdom,1978,(01):172-175.
  • 9Tao W,Wen R,Goddard MB. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa[J].Investigative Ophthalmology & Visual Science,2002,(10):3292-3298.
  • 10Sieving PA,Caruso RC,Tao W. Ciliary neurotrophic factor (CNTF) for human retinal degeneration:Phase I trial of CNTF delivered by encapsulated cell intraocular implants[J].Proceedings of the National Academy of Sciences(USA),2006,(10):3896-3901.doi:10.1073/pnas.0600236103.

同被引文献54

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部